Case Study - Stealth mode Gene Therapy biotech

Situation

A biotechnology client that launched in stealth mode with over $80 million in Private Equity investment. Specialising in AAV gene therapy, the company has clinical assets in early-stage development. To support its growth, our client partnered with Andrew Davis to deliver on critical technical operations hires.

Approach

A collaborative partnership was agreed to extend the client network with a robust, far-reaching search strategy. Andrew Davis delivered high-quality shortlists through the following channels:

- Direct network of client contacts
- Discreet marketing
- Allerton Bishop global candidate network
- Targeted headhunting from a jointly agreed list of companies

Action

Andrew provided tailored executive search and interim solutions. He worked closely with the clients Senior HR Director and Chief Development Officer to define candidate briefs, benchmark salaries and rates, and lead a focused sourcing and engagement campaign across the following key roles:

Senior Director, Process Development
Analytical Development Director
CMC Project Manager
Translational Science Consultant

Result

All four roles were successfully filled within the originally agreed brief and budget. Notably, two of the hired candidates have since been promoted. The process was managed end-to-end, including candidate preparation, interview coordination, and offer/resignation support, ensuring a smooth experience for both client and candidates.

Client Comment

“Andy is a trusted search partner to myself and our wider business. His industry knowledge and market-leading understanding of Technical Operations is a key reason why he is a preferred partner.”